CY1114799T1 - Παραγωγα τετραϋδροκινολινης για τη θεραπεια διαταραχων μετατραυματικου στρες - Google Patents

Παραγωγα τετραϋδροκινολινης για τη θεραπεια διαταραχων μετατραυματικου στρες

Info

Publication number
CY1114799T1
CY1114799T1 CY20141100085T CY141100085T CY1114799T1 CY 1114799 T1 CY1114799 T1 CY 1114799T1 CY 20141100085 T CY20141100085 T CY 20141100085T CY 141100085 T CY141100085 T CY 141100085T CY 1114799 T1 CY1114799 T1 CY 1114799T1
Authority
CY
Cyprus
Prior art keywords
treatment
tetraidrokinolin
postgraduate
products
stress disorders
Prior art date
Application number
CY20141100085T
Other languages
Greek (el)
English (en)
Inventor
François Jenck
Original Assignee
Actelion Pharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40467356&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1114799(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Actelion Pharmaceuticals Ltd. filed Critical Actelion Pharmaceuticals Ltd.
Publication of CY1114799T1 publication Critical patent/CY1114799T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CY20141100085T 2007-10-10 2014-02-04 Παραγωγα τετραϋδροκινολινης για τη θεραπεια διαταραχων μετατραυματικου στρες CY1114799T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2007054130 2007-10-10
EP08807937.1A EP2207550B1 (en) 2007-10-10 2008-10-09 Tetrahydroquinoline derivatives for treating post-traumatic stress disorders

Publications (1)

Publication Number Publication Date
CY1114799T1 true CY1114799T1 (el) 2016-12-14

Family

ID=40467356

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100085T CY1114799T1 (el) 2007-10-10 2014-02-04 Παραγωγα τετραϋδροκινολινης για τη θεραπεια διαταραχων μετατραυματικου στρες

Country Status (27)

Country Link
US (1) US9532985B2 (cg-RX-API-DMAC7.html)
EP (1) EP2207550B1 (cg-RX-API-DMAC7.html)
JP (1) JP5883222B2 (cg-RX-API-DMAC7.html)
KR (1) KR101733247B1 (cg-RX-API-DMAC7.html)
CN (1) CN101820878B (cg-RX-API-DMAC7.html)
AR (1) AR068768A1 (cg-RX-API-DMAC7.html)
AU (1) AU2008309194B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0818617A2 (cg-RX-API-DMAC7.html)
CA (1) CA2699504C (cg-RX-API-DMAC7.html)
CY (1) CY1114799T1 (cg-RX-API-DMAC7.html)
DK (1) DK2207550T3 (cg-RX-API-DMAC7.html)
EA (1) EA017443B1 (cg-RX-API-DMAC7.html)
ES (1) ES2444418T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20140214T1 (cg-RX-API-DMAC7.html)
IL (1) IL204838A (cg-RX-API-DMAC7.html)
MA (1) MA31800B1 (cg-RX-API-DMAC7.html)
MX (1) MX2010003711A (cg-RX-API-DMAC7.html)
MY (1) MY153044A (cg-RX-API-DMAC7.html)
NZ (1) NZ585086A (cg-RX-API-DMAC7.html)
PE (1) PE20091010A1 (cg-RX-API-DMAC7.html)
PL (1) PL2207550T3 (cg-RX-API-DMAC7.html)
PT (1) PT2207550E (cg-RX-API-DMAC7.html)
SI (1) SI2207550T1 (cg-RX-API-DMAC7.html)
TW (1) TWI428129B (cg-RX-API-DMAC7.html)
UA (1) UA99150C2 (cg-RX-API-DMAC7.html)
WO (1) WO2009047723A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA201003251B (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007337659A1 (en) 2006-12-22 2008-07-03 Actelion Pharmaceuticals Ltd. 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives
EP2307417A2 (en) 2008-06-25 2011-04-13 Actelion Pharmaceuticals Ltd. 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine compounds
EP2402322A1 (en) 2010-07-02 2012-01-04 Actelion Pharmaceuticals Ltd. 1,2,3,4-tetrahydroisoquinoline derivative and its use as orexin receptor antagonist
JP5744203B2 (ja) 2010-08-24 2015-07-08 アクテリオン ファーマシューティカルズ リミテッドActelion Pharmaceuticals Ltd オレキシン受容体拮抗薬としてのプロリンスルフォンアミド誘導体
CN103153963B (zh) 2010-09-22 2014-12-24 卫材R&D管理有限公司 环丙烷化合物
CN103201261A (zh) 2010-11-10 2013-07-10 埃科特莱茵药品有限公司 用作为食欲素受体拮抗剂的内酰胺衍生物
WO2012085852A1 (en) 2010-12-22 2012-06-28 Actelion Pharmaceuticals Ltd 3,8-diaza-bicyclo[4.2.0]oct-8-yl amides
US9303023B2 (en) 2011-02-18 2016-04-05 Actelion Pharmaceuticals Ltd. Pyrazole and imidazole derivatives useful as orexin antagonists
WO2012114252A1 (en) 2011-02-21 2012-08-30 Actelion Pharmaceuticals Ltd Novel indole and pyrrolopyridine amides
WO2013050938A1 (en) 2011-10-04 2013-04-11 Actelion Pharmaceuticals Ltd 3,7-diazabicyclo[3.3.1]nonane and 9-oxa-3,7-diazabicyclo[3.3.1]nonane derivatives
MX343837B (es) 2011-11-08 2016-11-24 Actelion Pharmaceuticals Ltd Derivados de 2 - (1,2,3 -triazol - 2 - il) benzamida y 3 - (1,2,3 - triazol - 2 - il) picolinamida.
ES2617863T3 (es) 2012-06-04 2017-06-20 Actelion Pharmaceuticals Ltd. Derivados de bencimidazol-prolina
SG11201502493XA (en) 2012-10-10 2015-04-29 Actelion Pharmaceuticals Ltd Orexin receptor antagonists which are [ortho bi (hetero )aryl]-[2-(meta bi (hetero )aryl)-pyrrolidin-1-yl]-methanone derivatives
CA2902135A1 (en) 2013-03-12 2014-09-18 Actelion Pharmaceuticals Ltd Azetidine amide derivatives as orexin receptor antagonists
UA119151C2 (uk) 2013-12-03 2019-05-10 Ідорсія Фармасьютікалз Лтд КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА
EA030137B1 (ru) 2013-12-03 2018-06-29 Идорсиа Фармасьютиклз Лтд Кристаллическая форма (s)-(2-(6-хлор-7-метил-1н-бензо[d]имидазол-2-ил)-2-метилпирролидин-1-ил)(5-метокси-2-(2h-1,2,3-триазол-2-ил)фенил)метанона и ее применение в качестве антагонистов орексинового рецептора
ES2696708T3 (es) 2013-12-04 2019-01-17 Idorsia Pharmaceuticals Ltd Uso de derivados de bencimidazol-prolina
RU2703297C2 (ru) 2014-10-23 2019-10-16 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Композиции и способы для лечения бессонницы
CN115710250A (zh) * 2017-08-01 2023-02-24 博健制药有限责任公司 一种食欲素受体拮抗剂的晶型及其制备方法和用途
WO2020007964A1 (en) 2018-07-05 2020-01-09 Idorsia Pharmaceuticals Ltd 2-(2-azabicyclo[3.1.0]hexan-1-yl)-1h-benzimidazole derivatives
WO2020007977A1 (en) 2018-07-06 2020-01-09 Idorsia Pharmaceuticals Ltd 7-trifluoromethyl-[1,4]diazepan derivatives
WO2020099511A1 (en) 2018-11-14 2020-05-22 Idorsia Pharmaceuticals Ltd Benzimidazole-2-methyl-morpholine derivatives
WO2023218023A1 (en) 2022-05-13 2023-11-16 Idorsia Pharmaceuticals Ltd Thiazoloaryl-methyl substituted cyclic hydrazine-n-carboxamide derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100393703C (zh) * 2000-03-14 2008-06-11 埃科特莱茵药品有限公司 1,2,3,4-四氢异喹啉的衍生物
JP4637089B2 (ja) * 2003-03-26 2011-02-23 アクテリオン ファーマシューティカルズ リミテッド アセトアミド誘導体
HRP20150371T1 (hr) * 2004-03-01 2015-05-08 Actelion Pharmaceuticals Ltd. Supstituirani derivati 1,2,3,4-tetrahidroizokinolina
US7501395B2 (en) * 2005-04-25 2009-03-10 Eisai R & D Management Co., Ltd. Method of screening for antianxiety drugs
JP4582722B2 (ja) 2006-03-15 2010-11-17 アクテリオン ファーマシューティカルズ リミテッド 記憶機能を向上させるテトラヒドロイソキノリン誘導体
EP2402322A1 (en) 2010-07-02 2012-01-04 Actelion Pharmaceuticals Ltd. 1,2,3,4-tetrahydroisoquinoline derivative and its use as orexin receptor antagonist

Also Published As

Publication number Publication date
TW200932231A (en) 2009-08-01
MX2010003711A (es) 2010-04-30
TWI428129B (zh) 2014-03-01
EA201000557A1 (ru) 2010-10-29
JP2011500550A (ja) 2011-01-06
ZA201003251B (en) 2011-07-27
US9532985B2 (en) 2017-01-03
ES2444418T3 (es) 2014-02-25
PL2207550T3 (pl) 2014-05-30
WO2009047723A2 (en) 2009-04-16
CN101820878B (zh) 2012-02-01
KR101733247B1 (ko) 2017-05-08
JP5883222B2 (ja) 2016-03-09
KR20100065203A (ko) 2010-06-15
HK1145440A1 (en) 2011-04-21
PT2207550E (pt) 2014-02-07
MA31800B1 (fr) 2010-10-01
DK2207550T3 (da) 2014-01-27
AU2008309194B2 (en) 2013-10-03
CA2699504A1 (en) 2009-04-16
BRPI0818617A2 (pt) 2015-04-07
HRP20140214T1 (hr) 2014-04-11
WO2009047723A3 (en) 2009-05-28
IL204838A (en) 2014-09-30
UA99150C2 (ru) 2012-07-25
EP2207550B1 (en) 2013-12-11
NZ585086A (en) 2012-03-30
MY153044A (en) 2014-12-31
EP2207550A2 (en) 2010-07-21
SI2207550T1 (sl) 2014-03-31
CN101820878A (zh) 2010-09-01
IL204838A0 (en) 2010-11-30
US20100234420A1 (en) 2010-09-16
AR068768A1 (es) 2009-12-02
PE20091010A1 (es) 2009-08-08
EA017443B1 (ru) 2012-12-28
AU2008309194A1 (en) 2009-04-16
CA2699504C (en) 2015-11-24

Similar Documents

Publication Publication Date Title
CY1114799T1 (el) Παραγωγα τετραϋδροκινολινης για τη θεραπεια διαταραχων μετατραυματικου στρες
CY1125202T1 (el) Συνδυασμοι που περιλαμβανουν παραγωγα 5-φαινοξυ-3η-πυριμιδιν-4-ονης και η χρηση αυτων για την προφυλαξη ή αγωγη λοιμωξης απο hiv
CY1126771T1 (el) Συνδυασμοι δολουτεγραβιρης και λαμιβουδινης για την αγωγη λοιμωξης απο hiv
CY1122761T1 (el) Διαμορφωτες φαρμακοκινητικων ιδιοτητων θεραπευτικων παραγοντων
CY1121416T1 (el) Yποκατεστημενοι νουκλεοζιτες, νουκλεοτιδια και αναλογα αυτων
CY1120832T1 (el) Τροποποιητες πυρηνικης μεταφορας και χρησεις αυτων
MX2022006783A (es) Nuevos derivados de metilquinazolinona.
CY1119488T1 (el) Παραγων για θεραπεια ή/και αποτροπη διαταραχης υπνου
CY1119771T1 (el) Ενωσεις αμινοπυριμιδινυλιου ως αναστολεις toy jak
CY1117719T1 (el) Παραγωγα αμινοπυριμιδινης ως διαμορφωτες της lrrk2
ATE519764T1 (de) Spiroindolinon-derivate
EA200901423A1 (ru) Бензимидазолы и содержащие их фармацевтические композиции
CY1117122T1 (el) Παραγωγα πυραζολοσπειροκετονης για χρηση ως αναστολεις ακετyλ-coa καρβοξυλασης
CY1116034T1 (el) 2-ανιλινοβενζιμιδαζολο-6-καρβοξαμιδια ως αντι-φλεγμονωδεις παραγοντες
CY1117792T1 (el) Ανταγωνιστες toy trpv4
ECSP12011625A (es) Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17
CY1112558T1 (el) Ενωσεις ν-μεθυλαμινομεθυλο ισοϊνδολης και συνθεσεις που τις περιλαμβανουν και μεθοδοι χρησης τους
EA201070786A1 (ru) Бензофуропиримидиноны
EA201200631A1 (ru) Ингибиторы репликации вируса иммунодефицита человека
CY1114983T1 (el) Συνθεση για τη θεραπεια της κυστικης ινωσης
CY1121999T1 (el) Φαρμακοτεχνικες μορφες συνδυασμου δαρουναβιρης
TW200738651A (en) Cyclohexyl sulfonamide derivatives
MX2019003373A (es) Compuestos de aza-indazol para usar en lesiones de tendones y/o ligamentos.
CY1113240T1 (el) Αλατα ενωσεων αναστολεα hiv
CY1118585T1 (el) Ενωση βενζοθειαζολονης